256 related articles for article (PubMed ID: 22684382)
1. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients.
Lee MS; Sachdeva R; Kim MH; Sachdeva R
J Invasive Cardiol; 2012 Jun; 24(6):278-81. PubMed ID: 22684382
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience.
Lee MS; Chun KJ; Tobis JM
Catheter Cardiovasc Interv; 2008 Feb; 71(3):306-11. PubMed ID: 18288757
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
Lee MS; Cheng RK; Kandzari DE; Kirtane AJ
Am J Cardiol; 2012 Jun; 109(12):1729-32. PubMed ID: 22465319
[TBL] [Abstract][Full Text] [Related]
6. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
7. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
[TBL] [Abstract][Full Text] [Related]
10. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy.
Tanaka K; Li H; Curran PJ; Takano Y; Arbit B; Currier JW; Yeatman LA; Kobashigawa JA; Tobis JM
Am J Cardiol; 2006 Apr; 97(8):1192-7. PubMed ID: 16616025
[TBL] [Abstract][Full Text] [Related]
11. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
[TBL] [Abstract][Full Text] [Related]
12. Clinical and angiographic outcomes with everolimus eluting stents for the treatment of cardiac allograft vasculopathy.
Azarbal B; Arbit B; Ramaraj R; Kittleson M; Young A; Czer L; Rafiei M; Currier J; Makkar R; Kobashigawa J
J Interv Cardiol; 2014 Feb; 27(1):73-9. PubMed ID: 24118198
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry).
Godino C; Parodi G; Furuichi S; Latib A; Barbagallo R; Goktekin O; Cera M; Mueller R; Tamburino C; Grube E; Di Mario C; Reimers B; Chieffo A; Antoniucci D; Colombo A; Sangiorgi GM
EuroIntervention; 2010 Apr; 5(8):906-16. PubMed ID: 20542775
[TBL] [Abstract][Full Text] [Related]
14. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
[TBL] [Abstract][Full Text] [Related]
16. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry.
Manari A; Ortolani P; Guastaroba P; Marzaroli P; Menozzi M; Magnavacchi P; Varani E; Vignali L; Campo G; Marzocchi A
J Cardiovasc Med (Hagerstown); 2011 Feb; 12(2):102-9. PubMed ID: 20814313
[TBL] [Abstract][Full Text] [Related]
19. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
[TBL] [Abstract][Full Text] [Related]
20. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
